You have 9 free searches left this month | for more free features.

CyBorD

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Multiple Myeloma Trial in Canada (Isatuximab)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • Edmonton, Alberta, Canada
  • +9 more
Feb 14, 2022

Multiple Myeloma Trial in United States (Daratumumab, Cyclophosphamide, Bortezomib)

Completed
  • Multiple Myeloma
  • Mobile, Alabama
  • +25 more
Oct 7, 2021

Light Chain (AL) Amyloidosis Trial in Worldwide (Birtamimab, Placebo, Standard of Care Chemotherapy)

Recruiting
  • Light Chain (AL) Amyloidosis
  • Hartford, Connecticut
  • +120 more
Aug 8, 2022

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022

AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)

Not yet recruiting
  • AL Amyloidosis
  • Bone Marrow Biopsy
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Jun 2, 2023

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

Active, not recruiting
  • Multiple Myeloma
  • High-Risk Cancer
  • Bortezomib following nonmyeloablative allogeneic transplant
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Aug 22, 2022

Multiple Myeloma Trial in Montréal (ECT-001 (UM171) expanded cord blood)

Active, not recruiting
  • Multiple Myeloma
  • ECT-001 (UM171) expanded cord blood
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maiso
Mar 8, 2022

Multiple Myeloma Trial in Galway (Daratumumab, Cyclophosphamide, Bortezomib)

Unknown status
  • Multiple Myeloma
  • Galway, Ireland
    Galway University Hospital
Mar 27, 2018

Amyloidosis; Systemic Trial in Beijing (Doxycycline, Bortezomib, Cyclophosphamide)

Completed
  • Amyloidosis; Systemic
  • Beijing, China
    Peking Union Medical College Hospital
Feb 19, 2021

Myeloma Multiple Trial in Siena (Daratumumab)

Recruiting
  • Myeloma Multiple
  • Siena, Italy
    Azienda Ospedaliera Universitaria Senese
Jun 17, 2019

Multiple Myeloma Trial in Guangzhou (Cyclophosphamide, Bortezomib, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
    Sun Yat-sen university cancer center
Apr 18, 2016

Amyloidosis Trial in Boston, Cambridge, London (GSK2315698 (CPHPC), GSK2398852 (anti-SAP mAb))

Terminated
  • Amyloidosis
  • GSK2315698 (CPHPC)
  • GSK2398852 (anti-SAP mAb)
  • Boston, Massachusetts
  • +2 more
Sep 25, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Scottsdale, Toronto (bortezomib, cyclophosphamide, dexamethasone)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +1 more
May 13, 2011